| 04:59a | VYNE THERAPEUTICS : Announces Contract Execution for AMZEEQ and ZILXI with Major.. | AQ |
| 01/21 | VYNE THERAPEUTICS : Signs Deal With Pharmacy Benefit Manager for FDA-Approved Sk.. | MT |
| 01/21 | VYNE THERAPEUTICS : Announces Contract Execution for AMZEEQ® (minocycline) and Z.. | AQ |
| 01/07 | VYNE THERAPEUTICS INC. : Regulation FD Disclosure, Financial Statements and Exhi.. | AQ |
| 01/05 | VYNE THERAPEUTICS : to Present at the LifeSci Partners 10th Annual Healthcare Co.. | AQ |
| 2020 | VYNE THERAPEUTICS : Completes End-of-Phase 2 Meeting With FDA for FCD105 to Trea.. | MT |
| 2020 | VYNE Therapeutics Reports Successful End-of-Phase 2 Meeting with the FDA for .. | GL |
| 2020 | VYNE THERAPEUTICS : to Join Nasdaq Biotechnology Index | MT |
| 2020 | VYNE THERAPEUTICS : Added to Nasdaq Biotechnology Index | AQ |
| 2020 | VYNE THERAPEUTICS : Wins US Patent for Acne Treatment Amzeeq | MT |
| 2020 | VYNE THERAPEUTICS : Announces New U.S. Patent Expiring in 2037 for AMZEEQ® (mino.. | AQ |
| 2020 | VYNE Therapeutics Announces Publication of Long-term Safety & Efficacy Data f.. | GL |
| 2020 | VYNE THERAPEUTICS : to Present at the 32nd Annual Piper Sandler Healthcare Confe.. | AQ |
| 2020 | VYNE Therapeutics to Present at the 32nd Annual Piper Sandler Healthcare Conf.. | GL |
| 2020 | VYNE THERAPEUTICS : Management's Discussion and Analysis of Financial Condition .. | AQ |
| 2020 | VYNE THERAPEUTICS INC. : Results of Operations and Financial Condition (form 8-K.. | AQ |
| 2020 | Earnings Flash (VYNE) VYNE THERAPEUTICS Posts Q3 EPS $-0.13, vs. Street Est o.. | MT |
| 2020 | Earnings Flash (VYNE) VYNE THERAPEUTICS Reports Q3 Revenue $3.3M, vs. Street .. | MT |
| 2020 | VYNE THERAPEUTICS : Reports Third Quarter 2020 Financial Results and Provides Bu.. | AQ |
| 2020 | VYNE Therapeutics Reports Third Quarter 2020 Financial Results and Provides B.. | GL |
| 2020 | VYNE THERAPEUTICS : to Report Third Quarter 2020 Financial Results on November 5.. | AQ |
| 2020 | VYNE Therapeutics to Report Third Quarter 2020 Financial Results on November .. | GL |
| 2020 | VYNE THERAPEUTICS : Announces Covered Status for ZILXI with Express Scripts | AQ |
| 2020 | VYNE THERAPEUTICS INC. : Regulation FD Disclosure, Financial Statements and Exhi.. | AQ |
| 2020 | VYNE THERAPEUTICS : Announces Covered Status for ZILXI™ (minocycline) with.. | AQ |
| 2020 | VYNE Therapeutics Announces Covered Status for ZILXI™ (minocycline) wit.. | GL |
| 2020 | VYNE THERAPEUTICS : Announces ZILXI topical foam, 1.5% is Available in Pharmacie.. | AQ |
| 2020 | VYNE THERAPEUTICS INC. : Regulation FD Disclosure, Financial Statements and Exhi.. | AQ |
| 2020 | VYNE THERAPEUTICS : Announces ZILXI™ (minocycline) topical foam, 1.5% is A.. | AQ |
| 2020 | VYNE THERAPEUTICS : Announces ZILXI™ (minocycline) topical foam, 1.5% Avai.. | PR |
| 2020 | VYNE Therapeutics Announces ZILXI™ (minocycline) topical foam, 1.5% is .. | GL |
| 2020 | VYNE THERAPEUTICS : to Host Physician Symposium on AMZEEQ and ZILXI | AQ |
| 2020 | VYNE THERAPEUTICS : to Host Physician Symposium on AMZEEQ® and ZILXI™ | AQ |
| 2020 | VYNE Therapeutics to Host Physician Symposium on AMZEEQ® and ZILXI™ | GL |
| 2020 | VYNE THERAPEUTICS : Announces the Appointment of Patrick G. LePore to its Board .. | AQ |
| 2020 | VYNE THERAPEUTICS INC. : Change in Directors or Principal Officers, Regulation F.. | AQ |
| 2020 | VYNE THERAPEUTICS : Announces the Appointment of Patrick G. LePore to its Board .. | AQ |
| 2020 | VYNE Therapeutics Announces the Appointment of Patrick G. LePore to its Boar.. | GL |
| 2020 | VYNE Therapeutics (formerly Menlo Therapeutics) to Present at the Cantor Fitz.. | GL |
| 2020 | MENLO THERAPEUTICS : Announces Completion of Corporate Name Change to VYNE Thera.. | AQ |
| 2020 | MENLO THERAPEUTICS : Announces Completion of Corporate Name Change to VYNE Thera.. | PR |
| 2020 | MENLO THERAPEUTICS INC. : Regulation FD Disclosure, Financial Statements and Exh.. | AQ |
| 2020 | MENLO THERAPEUTICS : Management's Discussion and Analysis of Financial Condition.. | AQ |
| 2020 | MENLO THERAPEUTICS INC. : Results of Operations and Financial Condition (form 8-.. | AQ |
| 2020 | Menlo Reports Second Quarter 2020 Financial Results and Provides Business Upd.. | GL |
| 2020 | MENLO THERAPEUTICS INC. : Submission of Matters to a Vote of Security Holders (f.. | AQ |
| 2020 | Menlo Therapeutics to Report Second Quarter 2020 Financial Results on August .. | GL |
| 2020 | MENLO THERAPEUTICS INC. : Changes in Registrant's Certifying Accountant, Financi.. | AQ |
| 2020 | MENLO THERAPEUTICS INC. : Entry into a Material Definitive Agreement, Financial .. | AQ |
| 2020 | MENLO THERAPEUTICS : Announces Pricing of Offering of Common Stock | AQ |
| 2020 | Menlo Therapeutics Announces Pricing of Offering of Common Stock | GL |
| 2020 | Menlo Therapeutics Announces Proposed Offering of Common Stock | GL |
| 2020 | MENLO THERAPEUTICS INC. : Other Events, Financial Statements and Exhibits (form .. | AQ |
| 2020 | Menlo Therapeutics Announces Positive Results from Phase 2 Trial of FCD105 fo.. | GL |
| 2020 | MENLO THERAPEUTICS INC. : Other Events, Financial Statements and Exhibits (form .. | AQ |
| 2020 | Menlo Therapeutics Receives FDA Approval of ZILXI™ (minocycline) topica.. | GL |
| 2020 | MENLO THERAPEUTICS : Announces Covered Status for AMZEEQ topical foam, 4%, on Ad.. | AQ |
| 2020 | Menlo Therapeutics Announces Covered Status for AMZEEQ® (minocycline) topical.. | GL |
| 2020 | Menlo Therapeutics to Present at the Jefferies Virtual Healthcare Conference | GL |
| 2020 | ROBBINS GELLER RUDMAN & DOWD LLP : Announce Proposed Settlement in the Menlo The.. | BU |
| 2020 | MENLO THERAPEUTICS : Steven Basta Joins the DermBiont, Inc. Board of Directors | AQ |
| 2020 | MENLO THERAPEUTICS : Management's Discussion and Analysis of Financial Condition.. | AQ |
| 2020 | MENLO THERAPEUTICS INC. : Results of Operations and Financial Condition, Financi.. | AQ |
| 2020 | Menlo Reports First Quarter 2020 Financial Results and Provides Business Upda.. | GL |
| 2020 | MENLO THERAPEUTICS : Financial Statements and Exhibits (form 8-K/A) | AQ |
| 2020 | Menlo Therapeutics to Report First Quarter 2020 Financial Results on May 11 | GL |
| 2020 | MENLO THERAPEUTICS : and Cutia Therapeutics Enter into Exclusive License Agreeme.. | AQ |
| 2020 | MENLO THERAPEUTICS INC. : Entry into a Material Definitive Agreement, Regulation.. | AQ |
| 2020 | Menlo Therapeutics and Cutia Therapeutics Enter into Exclusive License Agreem.. | GL |
| 2020 | MENLO THERAPEUTICS INC. : Change in Directors or Principal Officers (form 8-K) | AQ |
| 2020 | MENLO THERAPEUTICS INC. : Changes in Registrant's Certifying Accountant, Amendme.. | AQ |
| 2020 | Menlo Therapeutics Announces Results from Two Phase 3 Clinical Trials of Serl.. | GL |
| 2020 | Menlo Announces Settlement to Conclude Finacea Foam Litigation and Announces .. | GL |
| 2020 | MENLO THERAPEUTICS INC. : Change in Directors or Principal Officers, Amendment o.. | AQ |
| 2020 | Menlo Therapeutics Appoints Andrew Saik as Chief Financial Officer | GL |
Canada
Deutschland
España
France
Italia
Schweiz (DE)
United Kingdom
Report
